Skip to Content

Leflunomide

In the US, Leflunomide (leflunomide systemic) is a member of the following drug classes: antirheumatics, selective immunosuppressants and is used to treat Psoriatic Arthritis and Rheumatoid Arthritis.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA13

CAS registry number (Chemical Abstracts Service)

0075706-12-6

Chemical Formula

C12-H9-F3-N2-O2

Molecular Weight

270

Therapeutic Categories

Selective immunosuppressant

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Chemical Name

4-Isoxazolecarboxamide, 5-metyl-N-(4-trifluorometyl)phenyl)-

Foreign Names

Generic Names

  • Leflunomide (OS: USAN, BAN, JAN)
  • Léflunomide (OS: DCF)
  • HWA 486 (IS: HoechstMarion)
  • RS 34821 (IS: HoechstMarion)
  • SU 101 (IS: Sugen)
  • Leflunomide (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Leflunomidum (PH: Ph. Eur. 8)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide